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Abstract 
We have applied the Brouers-Sotolongo fractal kinetic equation (BSf(t,n,α)), improving 
notably the precision, to nine cases reported recently in the literature on drug release.  The 
reason of using this equation is that it contains as approximations some of the mostly used 
empirical formula used in that field. Moreover, this equation is now successfully employed for 
the investigation of sorption of contaminants in aqueous media. An important extension of the 
BSf(t,n,α) has been the introduction of variation of the fractal time coefficient (α(tν)). This 
improvement can lead to a greater precision of the fits and deduce some hint on the nature of 
the drug release process which can give precious information  to propose microscopic molecular 
ad hoc models. We, therefore, suggest the use of the BSf(t,n,α(tν)) formula, as a first step, in 
any detailed investigation and practical application of drug release data both in vitro and in vivo 
studies starting with the Weibull and Hill approximations to follow properly the physical 
solution. 
Keywords: Pharmacokinetics; Drug release; Fractal kinetic models; Brouers-Sotolongo 
equation; Time-dependent coefficient. 
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1. Introduction 
Drugs are a big part of the pharmaceutical compounds with extensive application in the 
treatment of human, fish, and poultry infections (Kalhori et al., 2017; Soori et al., 2016). In 
case of humans, the vast majority of drugs are manufactured in the form of tablets, capsules or 
suspensions which are taken orally (Al-Musawi et al., 2019; Swarbick and Boylan, 1996). At 
present, the manufacturing high-quality drugs has become a top priority of the pharmaceutical 
companies, therefore, several studies has been conducted by researchers in order to best 
describe of drug release process in body. Drug release is an important concept in the 
pharmaceutical sciences, it is defined as the mechanism of a drug molecule leaves its dosage 
form, and then it is subjected the processes of dissolution (desorption from surface), distribution 
in the release medium, metabolism and eventually becoming available for target sites of 
pharmacological action within the body (Singhvi and Singh, 2011).  
The study on the mathematical description of the absorption kinetics of drug release is a basic 
problem in pharmacokinetics and of importance to compare the therapeutic performance of 
different drugs, for example, generic and innovative ones (Sopasakis et al., 2018; Fernandez 
et al., 2011; Raval et al., 2010; Pereira, 2010). From another side, there is a necessity for the 
experimental data of drug release to be modeled and fitted with the used mathematical models 
in order to successfully analyze and optimize the design of the drug delivery systems. For many 
cases, the drug dissolution is the most important and predominated step in drug release in the 
body (Siepmann and Siepmann, 2012). Until recently, to study the drug dissolution profile in 
the form of its cumulative absorption i.e. the direct comparison of the experimental curves and 
the use of mathematical models to compare their statistical parameters, most authors have used 
well-known empirical equations derived from the theory of chemical kinetic reactions (linear, 
linearized, or nonlinear equations) (Selmi et al., 2018a; Sopasakis et al., 2018; Rostamizadeh 
et al., 2018). As in many similar problems, the two most popular equations in that field are the 
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Weibull (Kosmidis and Macheras, 2018; Barzegar-Jalali et al., 2008; Papaadopoulou et 
al., 2006) and the Hill (Goutelle et al., 2006; Korhonen et al., 2004; Mahayni  et al., 2000) 
equations. Other equations have been used in the literatures which are: zero, first, and second 
order, Higuchi, Hixson-Crowell, Korsmeyer-Peppas, Michaelis-Menten, and reciprocal 
powered time model equations (Singhvi and Singh, 2011; Barzegar-Jalali et al., 2008; 
Ramteke et al., 2014). We have cited some of the above mentioned equations for reasons which 
will appear later in the subsequent sections of the present paper.  
Other authors have developed more sophisticated (microscopic or mesoscopic) model based on 
the classical theory of diffusion to analyze drug release when microporous or mesoporous 
surfaces were involved (Vo et al., 2018; Barzegar-Jalali et al., 2008). These models are based 
on the consideration of the various diffusion steps, the chemical or physical nature of the 
interaction at the liquid-solid interface, the structure of the drug molecule, and the surface 
characteristics of the porous media. Generally, when used to fit experimental data, these models 
end up with approximations which are equivalent to some of the empirical formulas quoted 
above. One of the reasons is that there is no one to one correspondence between the more 
detailed and the empirical models which finally have to be used. The Weibull equation, the best 
example being, that can approximate and represent a number of different physical situations. 
Therefore, finding a methodology for modeling and fitting with precision the drug release 
curves which can unify and improve the above mentioned models is of great interest. In recent 
years, the application of fractal models like Brouers-Sotolongo kinetics formula (Brouers and 
Sotolongo-Costa, 2006; Brouers, 2014) in the modeling the kinetic diffusion data of organic 
and inorganic contaminants in the solid-liquid phases has been very satisfactory (Selmi et al., 
2018a; Selmi et al., 2018b; Brouers and Al-Musawi, 2018). Indeed, Brouers-Sotolongo 
model is based on a Burr-XII rigorous statistical function (Burr, 1942; Singh and Madala, 
1976) (a function equivalent to the deformed exponential introduced by Tsallis in its theory of 
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non-extensive entropy (Tsallis, 2002; Brouers et al., 2004; Picoli et al., 2003; Brouers and 
Sotolongo-Costa, 2005)). It is worth mentioning that the use of the Burr-XII distribution in 
chemical reactions in complex systems has been given theoretical ground in the works of the 
Wroclaw school based on stochastic and statistical theories (Jurlewicz and Weron, 1999).  
Due to the evolution in the computer software, many programs have been developed by 
scientific workers to solve, for example, the engineering problems. Recently, specific 
computational softwares have also been introduced for fitting process, particularly for kinetic 
dissolution curves. One of the more recent is the “kinetDS” one software proposed by (Mendyk 
et al., 2012; Krupa et al., 2018). This software was primarily designed for handling 
pharmaceutical dissolution tests. In addition, the nonlinear fitting algorithms built in the 
Mathematica technical computing software, in which the full calculation of the present study is 
done, is also widely utilized in the field of the modeling of the experimental data.   
The purpose of this paper is to show that the Brouers-Sotolongo model contains in itself all the 
mentioned empirical functions and get better precision than most of the methods used so far in 
field of drug release. We will thus compare the obtained results of our theory with those of a 
few recent papers which have employed empirical, semi-empirical, and computational methods, 
that some of them using a heavy mathematical formulation. We will show that in each of these 
cases, if we introduce a time variation of the fractal coefficient, we get better precision and 
reach quite similar physical conclusions. 
2. Theoretical model 
The Brouers-Sotolongo model has been used successfully, for example, quoting some of the 
most recent papers (Al-Musawi et al., 2017; Figaro et al., 2009; Unuabonah et al., 2019; 
Wakkel et al., 2019; Selmi et al., 2018a; Mbarki et al., 2018; Selmi et al., 2018b) in the field 
of sorption in aqueous phase on porous, micro and macro materials. Theoretically, Brouers-
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Sotolongo model has been legitimized by stochastic arguments (Jurlewicz and Weron, 1999). 
The Brouers-Sotolongo model, moreover, can provide simple expressions for the half-life 
sorption or release time scale as well as for parameter of the time-dependent rate which can 
give hints for the changes of the physico-chemical processes that appear during the evolution 
of the dissolution process. To demonstrate the usefulness of Brouers-Sotolongo model, we have 
analyzed the dissolution data of drug release that discussed in the original paper of (Mendyk 
et al., 2012; Krupa et al., 2018) and some representative published data (Vo et al., 2018; 
Siepmann and Peppas, 2001; Schlupp et al., 2011; Rostamizadeh et al., 2018).  
In the present study, the proposed Brouers-Sotolongo kinetic formula has been named 
BSf(t,n,α). The generalized form of BSf(t,n,α) model is a solution of the following equivalent 
fractal differential equations (eqs. 1 or 2): 
dq(t)
dta
= −
1
τ
q(t)n                                               (1) 
dq(t)
dt
= −
ata−1
τ
q(t)n                                          (2) 
Where q(t) is the quantity of drug released or dissolved molecules at specific sorption or release 
time (t, hr or day), τ is a characteristic time (hr or day), n is a parameter denoting to the 
fractional order of the reaction, and α is an essential constant representing the fractal time 
coefficient and can be used to macroscopically express the system complexity.   
In addition, BSf(t,n,α) model is a general form of the well-known first order differential model 
(eq.3), which gives the exponential function. 
dq(t)
dt 
= −
1
τ
q(t)                                                   (3)  
The solution of eq.1 depends on the limiting conditions, as shown below: 
If  q(0) = qi and q(∞) = qf    in which    qf ≪ qi or = 0, 
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Where qi is the initial drug quantity, and qf  is the quantity of drug which has not been released 
at the end of the process, one has the decay solution as shown in eq.(4), as follows: 
BSf(t, n, α) ≡ q(t) = (qi − qf)(1 + (n − 1) (
t
τ
)
α
)−(
1
n−1
) + qf                  (4) 
If q(0) = 0  and  q(∞) = qm   
where qm being the maximum released quantity of drug, one has the cumulative solution (eq.5): 
q(t)
qm
(%) = 1 − S(t)                                                               (5) 
With  S(t) = [1 + (n − 1) (
t
τ
)
a
]−
1
n−1                                     (6) 
Where S(t) has the form of the survival part of the cumulative Burr XII distribution function, 
and can be expresses as the deformed exponential distribution used in the statistical physics of 
complex systems in particular in the works on the non-extensive entropy (Tsallis, 2002). 
expn[x] = (1 − (n − 1)x)
−1/(n−1), with exp1[x] =  exp [x]                         (7)    
The two asymptotic trends of the S(t) are:  
i) For t ≪ τ        S(t) → 1 − (t/τ)a                              (8) 
ii) For t ≫ τ        S(t) → (t/τ)−(
a
n−1
)
                              (9) 
When (
α
n−1
) < 1, the Burr XII function belongs to the basin of attraction of the heavy tail 
Lévy distributions. 
The fractal differential equations (1 and 2) can be rewritten in the form of a first order 
differential equation as shown in Eq.10. 
dq(t) 
dt
= −R(t)q(t)                                                          (10) 
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Where R(t)  is a time dependent rate (or hazard function in reliability theory) (or intensity of 
transition in relaxation theory) (Jurlewicz and Weron, 1999; Brouers and Sotolongo-Costa, 
2006; Brouers, 2014; Kosmidis and Macheras, 2018; Papaadopoulou et al., 2006), which 
is calculated by using the following equation:  
R(t) = −
d
dt
ln( S(t)) =
1
τ(t)
=
α
τ
(t/τ)α−1
(1+(n−1)(
t
τ
))
                      (11)      
It is worth to note that the half time τ50% (hr or day) corresponding to q(t) =0.5 qm is given 
by: 
τ50% = τ(
(0.5)−n+1−1
n−1
)1/α                                                     (12) 
One of the interesting property of the BSf(t,n,α) formula is that it can yield most of the empirical 
formulas encountered in the literature. These empirical formulas can be expressed as 
approximations of the full BSf(t,n,α) equation giving them a more precise statistical signature, 
these formulas are: BSf(t,0,1) is zero- order kinetics equation; BSf(t,1,1) is-first order kinetics 
equation; BSf(t,2,1) is second order kinetics equation; BSf(t,1,α) is the Weibull kinetics 
equation; BSf(t,2,α) is the Hill (or log-logistic) kinetics equation; BSf(t,2,1) is the Michaelis-
Menten equation; BSf(t<<τ,1,α) is the Korsmeyer-Peppas kinetics equation, and 
BSf(t<<τ,1,1/2) is the Higuchi kinetics equation. Notably, a lag time can be introduced in these 
formulas if it is necessary. 
In some of our previous papers on sorption in porous materials, we had to introduce a time 
dependent fractal coefficient to account for the change of sorption conditions with time. This 
improvement of the theory can be used in this context too in order to achieve a better fit of the 
release curves. We assumed a power law behavior which is common in complex systems in the 
following form: 
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α(t) =  α0 + (αs − α0(t/ ts)
ν)                                                                             (13) 
Where ν is an empirical parameter, ts a time corresponding to the experimental saturation of 
the release, α0 and αs are the initial and at saturation time values of the power law, respectively. 
With this expression the solution of eq.(11)  
R(t) = (
t
τ
)
α(t)
(
1
t
a(t) +
1
ts
(as − a0) (
t 
ts
)
ν−1
ln (
t
ts
)/(1 + (n − 1) (
t
ts
)a(t))             (14) 
With a(t) given by eq.(13), in addition, Eq.(14) reduces to eq.(11) when as = a0. 
In the following, when we introduce a time dependent fractal coefficient (eq.13), BSf(t,n,α) 
will be written BSf(t,n,α(tν)). When n=1 or n= 2, we will call it Weibull or Hill, respectively. 
The solver software of BSf(t,n,α(tν)) has been built with the nonlinear fit of the program 
Mathematica (version 10). It is worth to mention that the accuracy of the fitting between the 
data and used models was evaluated in the light of the determined values of the regression 
coefficient, which were presented in six decimal places. 
3. Results and discussion 
3.1 Analysis the data of Cases 1-3 
Mendyk et al., (2012) have proposed an algorithm called “KinetDS” to analyze drug 
dissolution test data. They have applied it to three different cases to assess its usefulness. 
Alternatively, we have applied the BSf(t,n,α(tν)) formalism to treat  these three cases and 
obtained a clearly better fit and a better characterization of the relevant parameters. The first is 
the analysis of a simulation of data obtained from an exact Hill equation and reproduced in 
Table 4 of their paper (case 1). The second is the data obtained from the application of the 
KinetDS software to the simulation of a biphasic drug release consisting in a first rapid phase 
followed by a second exhibiting a linear evolution (case 2), these data are listed in Table 5 in 
Mendyk et al., (2012). The third is a real case situation, it is to say, the results published by 
Patel et al., (2008) in dissolution technologies (case 3) which were listed in Table 6 in Mendyk 
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et al., (2012). For this purpose the nonlinear modeling methods of Mathematica program was 
utilized for the determination of the model parameters. The analysis for the dissolution data of 
case 1 demonstrated that our methodology was reproduced the parameters of Hill model as 
accurately (R2=1) than those obtained from Mendyk et al., (2012) analysis (Table 1). Indeed, 
the data of dissolution profile (case 1) were presented perfectly by using Hill model as depicted 
in Figure 1.  
Table 1 listed the results of analysis of the two parts of case 2 data. At first, the data of each 
part were fitted separately and the results of fitting are depicted in Figure 2a. Secondly, we have 
fitted the whole curve (Figure 2b). All the models fit the data with R2 values> 0.999 (Table 1). 
It can be noticed that Weibull model was the best fitted model for each part of case 2 data, 
while, the whole data of these two parts fitted well with  BSf(t,n,α(tν)) model. 
The results of fitting of case 3 by Mendyk et al., (2012) showed that the Weibull model was 
satisfactory represented the data with R2 values of 0.9496 and 0.9541, respectively. The 
analysis of this study for case 3 data (Table 1) demonstrated that it can be reached to R2 values 
higher than 0.999. Moreover, BSf(t,n,α(tν)) model exhibited high precision values compared 
with the other used models. The data of case 3 and the best fitted curve is being shown in Fig. 
3a, as well as, the rate results are depicted in Fig. 3b. 
Table 1. The modeling results of cases 1, 2, and 3 drug release data 
Model 𝐪𝐦 𝐧 𝛂(𝐭
𝛎) 𝛖 𝛕𝟓𝟎% 𝐑
𝟐 
Case 1 
Weibull  1 3.37  6.47 0.99837 
Hill  2 5  6.31 1 
Case 2 
Weibull (First part of Fig. 2a)  1 0.30   0.999991 
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Weibull (second part of Fig. 2a)  1 0.71   0.999960 
Hill  2 0.68  1.67 0.998744 
Weibull   1 0.45  1.87 0.999769 
BSf(t,n,α(tν))  1.6 0.3-0.71 0.2  0.999911 
Case 3 
Weibull 100 1 0.91  4.07 0.999906 
Hill 100 2 1.66  4.09 0.999221 
BSf(t,n,α(tν)) 100 1.15 0.61-1.24 0.5  0.999990 
 
 
Figure 1. Fit of case 1 data (dotted points) with the Brouers-Sotolongo model (solid line) 
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Figure. 2. Fit of separately the two parts of the case 2 data (dotted points) with the Brouers-
Sotolongo model (solid line) (a), and fit the whole case 2 data with the same model (b) 
 
Figure 3. Fit of case 3 data (dotted points) with the Brouers-Sotolongo model (solid line) (a), 
and the rate results (b) 
3.2 Analysis the data of Cases 4-6 
In cases 4 and 5, we have applied the BSf(t,n,α(tν)) method to the experimental data of the 
upper curves of Fig.6a (case 4) and Fig.6b (case 5), respectively, of reference (Siepmann and 
Peppas, 2001). These authors have discussed the application of a set of usual empirical and 
a 
b 
a 
b 
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semi-empirical formulas to model drug release from delivery systems based on hydroxypropyl 
methylcellulose. They did not give any values of R2, but the comparison of their and our fitting 
shows clearly that the BSf(t,n,α(tν)) method is with values larger than 0.9999 yields a better 
representation of the evolution of the kinetics of the release and provides relevant and useful 
parameters as tabulated in Table 2. In addition, it can be abvioused from Figures 4 and 5 which 
depict the evolution curves corresponding to BSf(t,n,α(tν)) fitting with the the real data of cases 
4 and 5, respectively, that these two types of data can be fitted precicisally from inception to 
saturation condition by our theory. Also, the results indicated that the improvement in 
BSf(t,n,α(tν)) model by introducing the time dependent variable (ts) was necessary in studied 
cases to achieve a good fit of the drug release data. 
Vo et al., (2018) have used a complex mathematical model based on diffusion mechanisms to 
analyze the drug release from polymer-free coronar stemts with micorporous surfaces (case 6). 
This model predicts two stages of the release profile, which are a relatively initial rapid release 
of almost the entire drug followed by a slower process of the release of the remaining drug 
quantity. The first stage, in fact, is a diffusion process, while the second slow stage is due to an 
adsorption-desorption mechanism between the drug molecules in the release medium and the 
solid drug surface. The adsorption-desorption process occurs close to drug surface region 
depending on its surface roughness, which is can significantly affected the drug release amount 
via the effects of Van der Waals forces (see Fig. 2 in Vo et al., (2018)). Referring that the 
manufactured drug whose surface is rough has a large surface area, which is an important factor 
that can retard or improve the desorption rate of drug molecules from its exposure surfaces to 
desorption medium (Gultepe et al., 2010; Sulaymon et al., 2013). The model devised by Vo 
et al., (2018) and used to fit the experimental data presented in their paper has two drug release 
stages. The first is a rapid initial classical diffusive regime model until a characteristic time 
defining the transition t (this release was continued for a period of about 0.5 day). The second 
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stage, an adsorption-desorption regime influenced by the surface, is described by a 
sophisticated model depending on microscopic and mesoscopic geometrical and physical 
parameters of the system and results from the tedious solution of a set of differential and 
nonlinear equations. The second stage of the remaining drug release is relatively slow and 
extended for a period of about a week. 
We have analyzed these data with the BSf(t,n,α(tν)) method and the results showed that we 
can achieve as in the previous casas a precision R2> 0.999 (table 2), moreover, it can be 
observed from Fig.6a that BSf(t,n,α(tν)) captured the case 6 drug release data well. All the 
determined values of α is less than 1, suggesting fractal release process of the drug (Selmi et 
al., 2018b). Also, the calculated rate results according to eq.11 are displayed in Fig. 6b. The 
calculation of the time-dependent rate exhibits as in the Vo et al., (2018) paper a rapid followed 
by a much slower release rate. The curve exhibits a slight “bath tub” behavior due to the change 
of release mechanism, surface to volume sorption. 
Table 2. Results of the modeling of cases 4, 5, and 6 data 
Model n 𝛂 𝛖 𝐭𝐬 𝛕𝟓𝟎% 𝐑
𝟐 
Case 4 
Weibull 1 1.27   3.28 0.998517 
Hill 2 2.03   3.12 0.994740 
BSf(t,n,α(tν)) 1.08 0.88-2.20 1.2 11  0.999979 
Case 5 
Weibull 1 1.76   4.53 0.998898 
Hill 2 2.7   4.35 0.999185 
BSf(t,n,α(tν)) 1 1.4-2.7 2 11  0.999962 
Case 6 
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Weibull 1 0.37   0.040 0.998339 
Hill 2 0.61   0.037 0.999058 
BSf(t,n,α(tν)) 1.95 0.57-0.74 2 10  0.999271 
 
 
 
Figure 4. Fit of case 4 data (dotted points) with the Brouers-Sotolongo model (solid line) 
 
 
Figure 5. Fit of case 5 data (dotted points) with the Brouers-Sotolongo model (solid line) 
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Figure 6. Fit of case 6 data (dotted points) with the Brouers-Sotolongo model (solid line) (a), 
and the rate results (b) 
 
3.3 Analysis the data of Cases 7-9 
In case 7, we have analyzed Glucocorticoid drug release data from solid lipid nanoparticles 
with the time of release up to 8 hr, in particular the Figure 2 of study conducted by Schlupp et 
al., (2011). The authors concluded that these data are described by a two successive linear fit. 
The first line started from initial to 3 hr release time while the second line started from 4 to 8 
hr release time, with R2 values of 0.980 and 0.983, respectively. We have used the statistical 
BSf(t,n,α(tν)) equation to fit these data and reached similar above conclusions. The obtained 
value of R2 is much higher than the two values reported by Schlupp et al., (2011) (Table 3). In 
addition, the experimental points are well fitted by the nonlinear curve fitting results obtained 
from applying BSf(t,n,α(tν)) model as depicted in Fig. 7a. The complexity of the system is 
being represented by a fractal coefficient which is time dependent to represent a gradual change 
of release regime which is confirmed by the behavior of the rate (Fig. 7b) resulting by a change 
a 
b 
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with time of the fractal parameter which varies from 2.43 to 1.90. The obtained value of R2 is 
much higher than the two values reported by Schlupp et al., (2011) (Table 3). 
The last two cases concern the drug delivery of a conjugate of an antitumor conjugated with a 
copolymer and analyzed recently with Hill and Weibull formula by Rostamizadeh et al., 
(2018). The authors fitted the experimental data of drug release with six different models and 
the highest R2 value obtained did not exceed 0.86. In the two cases corresponding to two 
different media differing from their pH (case 8: the inner release profile of Fig. 8 at pH=7.4; 
case 9: the inner release profile of Fig.8 at pH=5.5, of that paper), our results are clearly better 
than those published in that paper (Figs. 8 and 9, and Tables 3). It is clear that the determined 
value of the statistical accuracy parameter was greater than 0.99 in many cases indicating the 
efficacy of our method to fit the drug release data. 
Table 3. Results of the modeling of case 7, 8, and 9 data. 
Model 𝐪𝐦 n 𝛂 𝛖 𝐭𝐬 𝛕𝟓𝟎% 𝐑
𝟐 
Case 7 
Weibull 90.44 1 1.64   2.17 0.999431 
Hill 97.04 2 2.24   2.42 0.999757 
Hill with α(tν) 100.44 2  2.43-1.90 2 10  0.999762 
Case 8 
Weibull 63 1 0.47   11.40 0.986907 
Hill 63 2 0.61   14.90 0.984134 
Hill with α(tν) 64 1.5 0.3-1.38 1.5 120  0.998129 
Case 9 
Weibull 10 1 0.77   10.90 0.992279 
Hill 10 2 1.24   14.60 0.989892 
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Hill with α(tν) 11.1 2 0.90-1.66 2 100  0.999399 
 
 
 
Figure 7. Fit of case 7 data (dotted points) with the Brouers-Sotolongo model (solid line) (a), 
and the rate results (b) 
4.  
Figure 8. Fit of case 8 data (dotted points) with the Brouers-Sotolongo model (solid 
line) 
b a 
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5.  
 Figure 9. Fit of case 9 data (dotted points) with the Brouers-Sotolongo model (solid line) 
 
 Conclusions 
We have applied the Brouers-Sotolongo fractal kinetics (BSf(t,n,α(tν)) equation to nine cases 
reported recently in the literature on drug release where were employed traditional semi-
empirical formulas and complex software. This formula, when the right approximations are 
performed, yields some of the commonly uses empirical ones used in this field. The 
(BSf(t,n,α(tν)) equation can be obtained by fundamental statistical and stochastic arguments. 
In each case we have obtained a better precision with fits characterized by a squared correlation 
factor (R2) values between 0.994 and 0.99999 most of the time much higher than the one 
published in the studied papers. This can be compared also with the compilation of drug release 
data of (Barzegar-Jalali et al., 2008) who reported the results of 106 studies with traditional 
methods and obtained 15 % of the  R2 values higher than 0.994 and 5% with  R2 higher than 
0.999. 
One of the feature of the (BSf(t,n,α(tν)) equation is that it includes a time-dependent fractal 
coefficient α(tν) which yields a much precise description of the time dependent rate in this 
problem in particular the values of the half-time release time and the maximum release and 
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allows guesses on the change with time of the physico-chemical nature of the release process. 
Another important consequence of introducing the time dependence of the fractal coefficient is 
to obtain a correct description of the time dependence of the rate function. In this paper we have 
encountered four different situations: 
α0 < 1  and   αs < 1       (case 6) 
α0 < 1  and     αs > 1     (cases 3; 4; 8, and 9) 
α0  > 1   and     αs > 1     (case 5) 
α0 > αs                            (case 7) 
The behavior of the rate is very different in each case. In the second one, the time variation has 
a non-monotonous “bath tub” shape which is not possible to obtain with a constant value of the 
fractal coefficient. The analysis assuming a variation with time of this coefficient allows us to 
take account of a possible change of nature of the release as a function of time. 
Our method can be confirmed, if necessary, with more sophisticated microscopic model 
keeping in mind that different microscopic models can yield, when averaged, to similar 
macroscopic ones. We, therefore, suggest the use of the (BSf(t,n,α(tν)) formula, as a first step, 
in any detailed investigation of release data both in vitro- and vivo studies starting with the 
Weibull and Hill approximations to be able to follow the physical solution in this nonlinear 
equation.  
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